Author Question: The Bipartisan Campaign Reform Act of 2002 targeted soft-money contributions. Indicate whether ... (Read 89 times)

theo

  • Hero Member
  • *****
  • Posts: 698
The Bipartisan Campaign Reform Act of 2002 targeted soft-money contributions.
 
  Indicate whether the statement is true or false

Question 2

In Brown v. Board of Education the Supreme Court did all of the following EXCEPT
 
  a. overturn the Plessy precedent.
  b. find de jure segregation unconstitutional.
  c. address the issue of de facto segregation.
  d. say that separate-but-equal schools were unconstitutional.
  e. find de facto segregation unconstitutional.



ricroger

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

T

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library